Cerus Corporation (CERS) at a glance

Cerus Corporation (CERS) is a small-cap Healthcare company. It trades at $2.67, with a -4.4% profit margin and revenue growth of 24.1%. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Growth (75/100) and its weakest is Safety (24/100). It carries above-market volatility, so expect larger swings.

Price

$2.68

Market cap

$512.9M

P/E ratio

n/a

Dividend yield

None

Beta

1.77

52-week range

$1.17 to $3.47